vs

Side-by-side financial comparison of Harmony Biosciences Holdings, Inc. (HRMY) and Cactus, Inc. (WHD). Click either name above to swap in a different company.

Cactus, Inc. is the larger business by last-quarter revenue ($388.3M vs $243.8M, roughly 1.6× Harmony Biosciences Holdings, Inc.). Cactus, Inc. runs the higher net margin — 10.4% vs 9.2%, a 1.1% gap on every dollar of revenue. On growth, Cactus, Inc. posted the faster year-over-year revenue change (38.5% vs 21.1%). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs 15.6%).

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

Cactus Club Cafe is a Canadian-owned chain of premium casual restaurants that originated in North Vancouver, British Columbia. The chain has since expanded to 34 locations throughout Canada, with other locations throughout British Columbia, Alberta, Saskatchewan, Ontario and the United States

HRMY vs WHD — Head-to-Head

Bigger by revenue
WHD
WHD
1.6× larger
WHD
$388.3M
$243.8M
HRMY
Growing faster (revenue YoY)
WHD
WHD
+17.4% gap
WHD
38.5%
21.1%
HRMY
Higher net margin
WHD
WHD
1.1% more per $
WHD
10.4%
9.2%
HRMY
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
15.6%
WHD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HRMY
HRMY
WHD
WHD
Revenue
$243.8M
$388.3M
Net Profit
$22.5M
$40.2M
Gross Margin
71.9%
Operating Margin
15.8%
9.9%
Net Margin
9.2%
10.4%
Revenue YoY
21.1%
38.5%
Net Profit YoY
-54.6%
-25.7%
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRMY
HRMY
WHD
WHD
Q1 26
$388.3M
Q4 25
$243.8M
$261.2M
Q3 25
$239.5M
$264.0M
Q2 25
$200.5M
$273.6M
Q1 25
$184.7M
$280.3M
Q4 24
$201.3M
$272.1M
Q3 24
$186.0M
$293.2M
Q2 24
$172.8M
$290.4M
Net Profit
HRMY
HRMY
WHD
WHD
Q1 26
$40.2M
Q4 25
$22.5M
$39.8M
Q3 25
$50.9M
$41.6M
Q2 25
$39.8M
$40.3M
Q1 25
$45.6M
$44.2M
Q4 24
$49.5M
$46.7M
Q3 24
$46.1M
$49.9M
Q2 24
$11.6M
$49.8M
Gross Margin
HRMY
HRMY
WHD
WHD
Q1 26
Q4 25
71.9%
36.2%
Q3 25
75.1%
36.8%
Q2 25
81.0%
36.6%
Q1 25
82.7%
38.4%
Q4 24
73.0%
37.8%
Q3 24
77.0%
39.0%
Q2 24
81.4%
39.2%
Operating Margin
HRMY
HRMY
WHD
WHD
Q1 26
9.9%
Q4 25
15.8%
22.9%
Q3 25
27.3%
23.2%
Q2 25
24.0%
22.2%
Q1 25
30.4%
24.5%
Q4 24
27.7%
25.9%
Q3 24
33.2%
26.2%
Q2 24
12.4%
27.5%
Net Margin
HRMY
HRMY
WHD
WHD
Q1 26
10.4%
Q4 25
9.2%
15.3%
Q3 25
21.2%
15.8%
Q2 25
19.8%
14.7%
Q1 25
24.7%
15.8%
Q4 24
24.6%
17.2%
Q3 24
24.8%
17.0%
Q2 24
6.7%
17.2%
EPS (diluted)
HRMY
HRMY
WHD
WHD
Q1 26
Q4 25
$0.38
Q3 25
$0.87
Q2 25
$0.68
Q1 25
$0.78
Q4 24
$0.85
Q3 24
$0.79
Q2 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRMY
HRMY
WHD
WHD
Cash + ST InvestmentsLiquidity on hand
$775.3M
$291.6M
Total DebtLower is stronger
$163.7M
Stockholders' EquityBook value
$870.2M
$1.4B
Total Assets
$1.3B
$2.5B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRMY
HRMY
WHD
WHD
Q1 26
$291.6M
Q4 25
$775.3M
$123.6M
Q3 25
$672.6M
$445.6M
Q2 25
$565.3M
$405.2M
Q1 25
$507.0M
$347.7M
Q4 24
$467.2M
$342.8M
Q3 24
$410.5M
$303.4M
Q2 24
$346.9M
$246.5M
Total Debt
HRMY
HRMY
WHD
WHD
Q1 26
Q4 25
$163.7M
$0
Q3 25
$168.5M
$0
Q2 25
$172.1M
$0
Q1 25
$175.7M
$0
Q4 24
$179.3M
$0
Q3 24
$182.8M
$0
Q2 24
$186.4M
$0
Stockholders' Equity
HRMY
HRMY
WHD
WHD
Q1 26
$1.4B
Q4 25
$870.2M
$1.2B
Q3 25
$835.1M
$1.2B
Q2 25
$773.1M
$1.1B
Q1 25
$720.5M
$1.1B
Q4 24
$659.2M
$1.1B
Q3 24
$596.8M
$1.0B
Q2 24
$538.6M
$954.7M
Total Assets
HRMY
HRMY
WHD
WHD
Q1 26
$2.5B
Q4 25
$1.3B
$1.9B
Q3 25
$1.2B
$1.9B
Q2 25
$1.1B
$1.8B
Q1 25
$1.1B
$1.8B
Q4 24
$999.2M
$1.7B
Q3 24
$928.1M
$1.7B
Q2 24
$858.4M
$1.6B
Debt / Equity
HRMY
HRMY
WHD
WHD
Q1 26
Q4 25
0.19×
0.00×
Q3 25
0.20×
0.00×
Q2 25
0.22×
0.00×
Q1 25
0.24×
0.00×
Q4 24
0.27×
0.00×
Q3 24
0.31×
0.00×
Q2 24
0.35×
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRMY
HRMY
WHD
WHD
Operating Cash FlowLast quarter
$126.2M
$128.3M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
2.5%
Cash ConversionOCF / Net Profit
5.61×
3.19×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRMY
HRMY
WHD
WHD
Q1 26
$128.3M
Q4 25
$126.2M
$72.3M
Q3 25
$108.7M
$61.8M
Q2 25
$79.3M
$82.8M
Q1 25
$34.0M
$41.5M
Q4 24
$75.6M
$66.6M
Q3 24
$70.5M
$85.3M
Q2 24
$42.6M
$78.0M
Free Cash Flow
HRMY
HRMY
WHD
WHD
Q1 26
Q4 25
$126.0M
Q3 25
$108.7M
Q2 25
$79.3M
Q1 25
$33.9M
Q4 24
$75.0M
Q3 24
$70.5M
Q2 24
$42.0M
FCF Margin
HRMY
HRMY
WHD
WHD
Q1 26
Q4 25
51.7%
Q3 25
45.4%
Q2 25
39.6%
Q1 25
18.3%
Q4 24
37.3%
Q3 24
37.9%
Q2 24
24.3%
Capex Intensity
HRMY
HRMY
WHD
WHD
Q1 26
2.5%
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.0%
Q2 24
0.4%
Cash Conversion
HRMY
HRMY
WHD
WHD
Q1 26
3.19×
Q4 25
5.61×
1.81×
Q3 25
2.14×
1.48×
Q2 25
1.99×
2.05×
Q1 25
0.75×
0.94×
Q4 24
1.53×
1.43×
Q3 24
1.53×
1.71×
Q2 24
3.68×
1.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRMY
HRMY

Segment breakdown not available.

WHD
WHD

Revenue$300.2M77%
Other$88.2M23%

Related Comparisons